Christopher Parks, MD
Internal Medicine · Newnan, GANPI 1962436329
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (54.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Intuitive Surgical at 58.3% of the total. Reporting peaked in 2023 at $6,373 and has fallen 96.9% since, to $197 in 2025. Among internal medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 158 payments — averaging $76.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Pinnacle Biologics, Inc$3K
- Merck$480
- Novartis$456
- AstraZeneca$298
- Johnson & Johnson$287
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$2,50021%
- Food & beverage$2,98825%
- Education$6,67355%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 11 | $7,085 |
| Pinnacle Biologics, Inc | 2 | $2,518 |
| Merck | 29 | $480 |
| Novartis | 32 | $456 |
| AstraZeneca | 17 | $298 |
| Johnson & Johnson(3 entities) | 11 | $287 |
| Amgen | 13 | $203 |
| Regeneron Healthcare Solutions, Inc. | 4 | $169 |
| E.r. Squibb & Sons, L.L.C. | 12 | $137 |
| CSA Medical, Inc | 1 | $134 |
| Bristol Myers Squibb | 5 | $75 |
| Exelixis Inc. | 5 | $61 |
| GSK | 1 | $34 |
| Bayer | 2 | $34 |
| Pfizer | 2 | $28 |
| Fortovia Therapeutics, Inc. | 2 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Acacia Pharma Inc | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Sirtex Medical Inc | 1 | $17 |
| Conmed Corporation | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Sanofi | 1 | $13 |
| Coherus Oncology, Inc. | 1 | $12 |
| Kyowa Kirin, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,017
- Photofrin$2,500
- LIBTAYO$123
How this compares
$12,162 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $331 |
| Prednisone | 15 | $59 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Newnan
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.